G87(P) A retrospective review of deaths in trisomy 21: a tertiary centre's experience since the millennium. (12th March 2018)

• Record Type: Journal Article
• Authors: Shires, P; Marder, E; Vyas, H
• Is Part Of: Archives of disease in childhood. Volume 103(2018)Supplement 1
• Page Start: A36
• Page End: A36
• Publication Date: 2018-03-12
• Subjects: Children -- Diseases -- Periodicals; Infants -- Diseases -- Periodicals; 618.920005
• DOI: 10.1136/archdischild-2018-rcpch.85
• Languages: English
• ISSNs: 0003-9888

Abstract

Abstract : Aims: Children with Trisomy 21 often have complex health needs and are at increased risk of mortality than age-matched peers. A retrospective review was undertaken of children with Trisomy 21 who had died at our tertiary centre since the millennium. We audited demographics, cause of death and preceding events to identify any themes. Methods: A retrospective review of electronic, paper and archived microfilm patient records was undertaken in those with a diagnosis of Trisomy 21 who died in our trust after the millennium. Results: 16 cases were identified; the mean age at death was 34 months (ranging 2 days – 15 years). 50% of deaths occurred within the first year of life. Of the 13 cases where a cause of death was identified, cardiac pathology was attributed in 2 of 13 cases. Infection was implicated in 9 out of 13 cases, with 7 cases of primarily respiratory illness and 2 cases of line sepsis. Underlying respiratory disease was a significant contributing factor in 4 out of 13 cases. There was 1 case of Trisomy 21 with co-existent lethal skeletal dysplasia and 1 death related to congenital airway abnormality. In the 6 cases where immune function was tested, only one had completely normal function. Conclusions: The burden of cardio-respiratory disease in Trisomy 21 is well recognised. In our experience, sepsis, particularly with respiratory focus, was responsible for a high proportion of deaths. It is important that health care professionals have an awareness of the increased susceptibility and risk of mortality related to sepsis in children with Trisomy 21. The recognised association with impaired immune functioning in Trisomy 21, coupled with underlying cardio-respiratory co-morbidities, may heighten susceptibility to mortality in sepsis. To exacerbate this, communication and behavioural difficulties can make assessment more challenging and may mask or impede recognition of the severity of illness. Therefore, it is important for clinicians to be mindful of sepsis and have a low threshold for initiating early and aggressive management including timely administration of antibiotics.